Epstein Secrets

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

/19/201910:57 Entered By: Notes: Request No: 1905197( ) Note Type: Status Management Department: Pathology DateTime: 08117201911:16 Entered By: Edrs Service Notes: 19138788_UPDATE_20190817_111227.pdf Note Type: Status Management Department: Pathology Date Time: 08/17/201911:15 Entered By: Cms System

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

19 09:36 Entered By: Men Naka no match to records. Delta:me: 08/122019 17:14 Entered By: Nicholas Schultz Dater/me:08/1112019 19:40 Entered By: Edrs Service Datertme: 08/11/2019 19:40 Entered By: Cms System DateTime: 08/11/2019 18:11 Entered By: Sneyder Desousa Cotentin: 08/11/2019 17:41 Entered By:

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n

om 07/23/2019. These were entered into the CMS record. Note Type: Status Management Department: Pathology Dafertme: 08/11/2019 19:40 Entered By: Edrs Service Notes: 19136788_UPDATE_20190811_193631.pcif Note Type: Status Management Department' Pathology DateTime: 08/11/2019 19:40 Entered By: Cms System